Jesper Hallas (Anton Pottegard, Anton Pottegård, A Pottegård)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 132

Top Venues

Pharmacoepidemiology and drug safety

British journal of clinical pharmacology

Basic & clinical pharmacology & toxicology

Diabetes, obesity & metabolism

University of Southern Denmark

University of Southern Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern Denmark

Denmark

Professor :: Clinical Pharmacology and Pharmacy

Odense University Hospital

Denmark

Head of Research :: Hospital Pharmacy

Copenhagen Sønderbro Pharmacy

Denmark

Project Pharmacist

University of Southern Denmark

Denmark

Associate professor :: Clinical Pharmacology and Pharmacy

University of Southern Denmark

Denmark

PostDoc :: Clinical Pharmacology and Pharmacy

University of Southern Denmark Sep 01 2011

Denmark

PhD-student :: Clinical Pharmacology and Pharmacy

Education History

University of Southern Denmark

Denmark

PHD

Publications

Ditte Bork Iversen, Ann-Cathrine Dalgård Dunvald, Martin Thomsen Ernst, Shahab Abtahi, Patrick C Souverein, Olaf H Klungel, Glenn Brøde Jeppesen, Flemming Nielsen, Flemming Nielsen, Helen S Hammer, Oliver Pötz, Per Damkier, Erkka Järvinen, Jesper Hallas, Tore Bjerregaard Stage
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users. British journal of clinical pharmacology (2024)
Emma Bjørk, Rune Munck Aabenhus, Søren P Larsen, Jesper Ryg, Daniel Pilsgaard Henriksen, Carina Lundby, Jesper Hallas
Use of antibiotics for urinary tract infections up to and after care home admission in Denmark: a nationwide study. European geriatric medicine 15 (3) (2024)
Kamille Herskind, Peter Bjødstrup Jensen, Christina Anne Vinter, Lone Krebs, Lene Friis Eskildsen, Anne Broe, Jesper Hallas, Mette Bliddal
Validation of Obstetric Diagnosis and Procedure Codes in the Danish National Patient Registry in 2017. Clinical epidemiology 16 (2024)
Rahma Elmahdi, Daniel J Ward, Martin T Ernst, Gry Juul Poulsen, Nina Sahlertz Kristiansen, Jesper Hallas, Tine Jess
Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study. BMJ open 14 (2) (2024)
Jesper Hallas, Lars Ulrik Gerdes, Jakob Langballe Wetche, Wade Thompson
Does LDL-C determination method affect statin prescribing for primary prevention? A register-based study in Southern Denmark. European heart journal. Cardiovascular pharmacotherapy (2024)
Jesper Hallas, Jacob H Andersen, Jens Søndergaard, Lotte Rasmussen, Helene Kildegaard, Tina Vilsbøll, Reimar W Thomsen
Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose-lowering therapies. Diabetes, obesity & metabolism (2024)
Rahma Elmahdi, Daniel J Ward, Martin T Ernst, Gry Juul Poulsen, Nina Sahlertz Kristiansen, Jesper Hallas, Tine Jess
Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study. BMJ open 14 (2) (2024)
Emma Bjørk, Rune Munck Aabenhus, Søren P Larsen, Jesper Ryg, Daniel Pilsgaard Henriksen, Carina Lundby, Jesper Hallas
Use of antibiotics for urinary tract infections up to and after care home admission in Denmark: a nationwide study. European geriatric medicine 15 (3) (2024)
Tamino Zappalà, Jesper Hallas, Carola A Huber, Daphne Reinau, Christoph R Meier, Julia Spoendlin
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data. Pharmacoepidemiology and drug safety 33 (9) (2024)
Emma Bjørk, Rune Munck Aabenhus, Søren P Larsen, Jesper Ryg, Daniel Pilsgaard Henriksen, Carina Lundby, Jesper Hallas
Use of antibiotics for urinary tract infections up to and after care home admission in Denmark: a nationwide study. European geriatric medicine 15 (3) (2024)
Emma Bjørk, Rune Munck Aabenhus, Søren P Larsen, Jesper Ryg, Daniel Pilsgaard Henriksen, Carina Lundby, Jesper Hallas
Use of antibiotics for urinary tract infections up to and after care home admission in Denmark: a nationwide study. European geriatric medicine 15 (3) (2024)
Emma Bjørk, Rune Munck Aabenhus, Søren P Larsen, Jesper Ryg, Daniel Pilsgaard Henriksen, Carina Lundby, Jesper Hallas
Use of antibiotics for urinary tract infections up to and after care home admission in Denmark: a nationwide study. European geriatric medicine (2024)
Lotte Rasmussen, Jacob Harbo Andersen, Øystein Karlstad, Diego Hernan Giunta, Marie Linder, Kari Furu, Jesper Hallas
Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register-based drug utilization study. Diabetes, obesity & metabolism (2024)
Efe Eworuke, Mayura U Shinde, Laura Hou, J Michael Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Jesper Hallas, Daniel Scarnecchia, Yuanling Liang, Deborah Johnson, Robert W Platt, Hana Lee, Marie C Bradley
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark. Pharmacoepidemiology and drug safety 33 (9) (2024)
Aurelie Mailhac, Lars Pedersen, Jesper Hallas, Jens Soendergaard, Torben Mogensen, Henrik Toft Sorensen, Reimar Wernich Thomsen
Semaglutide (Ozempic ® ) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss. Clinical epidemiology 16 (2024)
Kamille Herskind, Peter Bjødstrup Jensen, Christina Anne Vinter, Lone Krebs, Lene Friis Eskildsen, Anne Broe, Jesper Hallas, Mette Bliddal
Validation of Obstetric Diagnosis and Procedure Codes in the Danish National Patient Registry in 2017. Clinical epidemiology 16 (2024)
Heidi Stubmark, Søren P Larsen, Emma Bjørk, Jesper Hallas, Carina Lundby
Medication management in Danish home health care: Mapping of tasks and time consumption. Basic & clinical pharmacology & toxicology (2024)
Lene Vestergaard Ravn-Nielsen, Emma Bjørk, Marianne Nielsen, Stine Galsgaard, Jesper Hallas, Carina Lundby
Challenges related to transitioning from hospital to temporary care at a skilled nursing facility: a descriptive study. European geriatric medicine (2024)
Louise Ladebo Rasmussen, Martin Thomsen Ernst, Aurelie Mailhac, Carsten Dirksen, Kirstine Nyvold Bojsen-Møller, Jesper Hallas
Real-World Use of Semaglutide for Weight Management: Patient Characteristics and Dose Titration-A Danish Cohort Study. Diabetes care (2024)
Rahma Elmahdi, Daniel J Ward, Martin T Ernst, Gry Juul Poulsen, Nina Sahlertz Kristiansen, Jesper Hallas, Tine Jess
Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study. BMJ open 14 (2) (2024)
Carina Lundby, Marianne Nielsen, Trine Simonsen, Stine Galsgaard, Maija Bruun Haastrup, Lene Vestergaard Ravn-Nielsen, Jesper Hallas
Attitudes towards deprescribing in geriatric psychiatry: A survey among older psychiatric outpatients. Basic & clinical pharmacology & toxicology (2023)
Ann-Cathrine Dalgård Dunvald, Flemming Nielsen, Dorte Aalund Olsen, Martin Thomsen Ernst, Louise Donnelly, Enrique Soto-Pedre, Maja Refshauge Kristiansen, Jens Steen Nielsen, Frederik Persson, Kurt Højlund, Jonna Skov Madsen, Jens Søndergaard, Ewan Pearson, Jesper Hallas, Tore Bjerregaard Stage
Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin - but not through altered drug metabolism in patients with type 2 diabetes. British journal of clinical pharmacology (2023)
Lars Christian Lund, Patricia Hjorslev Jensen, Jesper Hallas, Morten Andersen, Nicole L Pratt, Nina Sahlertz Kristiansen
Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis. Diabetes, obesity & metabolism (2023)
Lars Christian Lund, Patricia Hjorslev Jensen, Jesper Hallas, Morten Andersen, Nicole Pratt, Jesper Hallas
Identifying diabetogenic drugs using real world healthcare databases: a Danish and Australian symmetry analysis. Diabetes, obesity & metabolism (2023)
Alaa Burghle, Jesper Hallas, Malthe Rasmussen, Belinda Bruun, Jens Roost Hosbjerg, Carina Lundby
Use of analgesics in Denmark: A national survey. Basic & clinical pharmacology & toxicology 132 (4) (2023)
Alaa Burghle, Jesper Hallas, Malthe Rasmussen, Belinda Bruun, Jens Roost Hosbjerg, Carina Lundby
Use of analgesics in Denmark: A national survey. Basic & clinical pharmacology & toxicology (2023)
Nikolaj Mannering, Dennis Lund Hansen, Jesper Hallas, Henrik Frederiksen
Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population-based study. Transfusion 63 (2) (2023)
Camilla Lynnerup, Charlotte Verner Rossing, Morten Sodemann, Jesper Ryg, Jesper Hallas, Dorthe Susanne Nielsen
Perspectives on medication safety from vulnerable older migrants and their relatives-A qualitative explorative study. Basic & clinical pharmacology & toxicology (2023)
Jesper Hallas, Jacob Harbo Andersen, Jens Soendergaard, Reimar Wernich Thomsen, Tina Vilsbøll
Changes in the use of glucose-lowering drugs: A Danish nationwide study. Diabetes, obesity & metabolism 25 (4) (2023)
Alaa Burghle, Jesper Hallas, Malthe Rasmussen, Belinda Bruun, Jens Roost Hosbjerg, Carina Lundby
Use of analgesics in Denmark: A national survey. Basic & clinical pharmacology & toxicology (2023)
Jesper Hallas, Jacob Harbo Andersen, Jens Soendergaard, Reimar Wernich Thomsen, Tina Vilsbøll
Changes in the use of glucose-lowering drugs: A Danish nationwide study. Diabetes, obesity & metabolism 25 (4) (2023)
Alaa Burghle, Jesper Hallas, Malthe Rasmussen, Belinda Bruun, Jens Roost Hosbjerg, Carina Lundby
Use of analgesics in Denmark: A national survey. Basic & clinical pharmacology & toxicology 132 (4) (2023)
Nikolaj Mannering, Dennis Lund Hansen, Jesper Hallas, Henrik Frederiksen
Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population-based study. Transfusion 63 (2) (2023)
Nikolaj Mannering, Dennis Lund Hansen, Jesper Hallas, Henrik Frederiksen
Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population-based study. Transfusion (2023)
Melker Staffan Johansson, Jesper Hallas, Jens Soendergaard, Martin Englund, Dorte Thalund Grønne, Søren Thorgaard Skou, Ewa M Roos, Jonas Bloch Thorlund
Use of prescribed analgesics before and after exercise therapy and patient education in patients with knee or hip osteoarthritis. Rheumatology international (2023)
Erkka Järvinen, Ann-Cathrine Dalgård Dunvald, Martin Thomsen Ernst, Helen S Hammer, Oliver Pötz, Jesper Hallas, Tore Bjerregaard Stage
Dicloxacillin-Warfarin Drug-Drug Interaction - A Register-Based Study and In Vitro Investigations in 3D Spheroid Primary Human Hepatocytes. British journal of clinical pharmacology (2023)
Alaa Burghle, Jesper Hallas, Malthe Rasmussen, Belinda Bruun, Jens Roost Hosbjerg, Carina Lundby
Use of analgesics in Denmark: A national survey. Basic & clinical pharmacology & toxicology 132 (4) (2023)
Jesper Hallas, Jacob Harbo Andersen, Jens Soendergaard, Reimar Wernich Thomsen, Tina Vilsbøll
Changes in the use of glucose-lowering drugs: A Danish nationwide study. Diabetes, obesity & metabolism 25 (4) (2023)
Nikolaj Mannering, Dennis Lund Hansen, Jesper Hallas, Henrik Frederiksen
Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population-based study. Transfusion 63 (2) (2023)
J J Komen, Nicholas B Hunt, Jesper Hallas, P Hjemdahl, B Wettermark, M Olesen, M Bennie, Tanja Mueller, R Carragher, Øystein Karlstad, L J Kjerpeseth, O H Klungel, T Forslund
Heterogeneity after harmonisation: a retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries. Pharmacoepidemiology and drug safety (2023)
Camilla Lynnerup, Charlotte Rossing, Morten Sodemann, Jesper Ryg, Jesper Hallas, Dorthe Nielsen
Perspectives on medication safety from vulnerable older migrants and their relatives - a qualitative explorative study. Basic & clinical pharmacology & toxicology (2023)
Jesper Hallas, Anne Mette Skov Sørensen, Morten Olesen, Lotte Rasmussen
Opioid prescriber responsibility: A Danish drug utilization study. British journal of clinical pharmacology (2022)
Inge Raadal Skov, Hanne Madsen, Daniel Pilsgaard Henriksen, Jacob Harbo Andersen, Jesper Hallas, Jesper Rømhild Davidsen
Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality. The European respiratory journal 60 (3) (2022)
Jesper Hallas, Jacob H Andersen, Jens Søndergaard, Reimar W Thomsen, Tina Vilsbøll
Changes in use of glucose-lowering drugs: A Danish nationwide study. Diabetes, obesity & metabolism (2022)
Shirley V Wang, Jesper Hallas, William Crown, Peter Arlett, Darren M Ashcroft, Eric I Benchimol, Marc L Berger, Gracy Crane, Wim Goettsch, Wei Hua, Shaum Kabadi, David M Kern, Xavier Kurz, Sinead Langan, Takahiro Nonaka, Lucinda Orsini, Susanna Perez-Gutthann, Simone Pinheiro, Nicole L Pratt, Sebastian G Schneeweiss, Massoud Toussi, Rebecca J Williams
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Pharmacoepidemiology and drug safety (2022)
Mikkel Hojlund, Lárus Steinþór Guðmundsson, Jacob Harbo Andersen, Leena K Saastamoinen, Helga Zoega, Svetlana Ondrasova Skurtveit, Jonas W Wastesson, Nina Sahlertz Kristiansen, Jesper Hallas
Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020. Basic & clinical pharmacology & toxicology (2022)
Mikkel Hojlund, Lotte Rasmussen, Morten Olesen, Trine Munk-Olsen, Jesper Hallas
Who prescribes quetiapine in Denmark? British journal of clinical pharmacology 88 (9) (2022)
Jesper Hallas, Jacob Harbo Andersen, Jens Soendergaard, Reimar Wernich Thomsen, Tina Vilsbøll
Changes in the use of glucose-lowering drugs: A Danish nationwide study. Diabetes, obesity & metabolism (2022)
Christina Mortensen, Karina Dahl Steffensen, Emma Simonsen, Kamille Herskind, Jonna Skov Madsen, Dorte Aalund Olsen, Ditte Bork Iversen, Troels Korshøj Bergmann, Jesper Hallas, Tore Bjerregaard Stage
Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer. Pain (2022)
Anne Katrine Duun-Henriksen, Christian Dehlendorff, Martin Andreas Røder, Charlotte Skriver, Jesper Hallas, Søren Friis, Martin Andreas Røder, Signe Benzon Larsen
Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosis. Acta oncologica (Stockholm, Sweden) 61 (8) (2022)
Christina Mortensen, Karina Dahl Steffensen, Emma Simonsen, Kamille Herskind, Jonna Skov Madsen, Dorte Aalund Olsen, Ditte Bork Iversen, Troels Korshøj Bergmann, Jesper Hallas, Tore Bjerregaard Stage
Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in ovarian cancer patients. Pain (2022)
Inge Raadal Skov, Hanne Madsen, Jacob Harbo Andersen, Jesper Hallas, Jesper Rømhild Davidsen
Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults. ERJ open research 8 (3) (2022)
Mette Bliddal, Helene Kildegaard, Lotte Rasmussen, Martin Thomsen Ernst, Poul Jørgen Jennum, Stine Hasling Mogensen, Jesper Hallas, Rikke Wesselhoeft
Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study. European child & adolescent psychiatry (2022)
Joris J Komen, Jesper Hallas, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Nina Sahlertz Kristiansen, Morten Olesen, Marion Bennie, Tanja Mueller, Raymond Carragher, Øystein Karlstad, Lars Jøran Kjerpeseth, Olaf H Klungel
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. European heart journal 43 (37) (2022)
Ditte Bork Iversen, Nanna Elman Andersen, Ann-Cathrine Dalgård Dunvald, Jesper Hallas, Tore Bjerregaard Stage
Drug metabolism and drug transport of the 100 most prescribed oral drugs. Basic & clinical pharmacology & toxicology 131 (5) (2022)
Jesper Hallas, Jacob Harbo Andersen, Jens Soendergaard, Reimar Wernich Thomsen, Tina Vilsbøll
Changes in the use of glucose-lowering drugs: A Danish nationwide study. Diabetes, obesity & metabolism (2022)
Jesper Hallas
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case-control study designs. Pharmacoepidemiology and drug safety 31 (8) (2022)
Kasper Bruun Kristensen, Søren Friis, Lars Christian Lund, Jesper Hallas, Chris R Cardwell, Bettina Kulle Andreassen, Laurel A Habel, Jesper Hallas
Identification of Drug-Cancer Associations: A Nationwide Screening Study. Cancer research communications 2 (6) (2022)
Lotte Rasmussen, Björn Wettermark, Douglas Steinke, Jesper Hallas
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual-level drug dispensing data. Pharmacoepidemiology and drug safety 31 (10) (2022)
Jeremy A Rassen, Patrick Blin, Sebastian Kloss, Romain S Neugebauer, Robert W Platt, Jesper Hallas, Sebastian G Schneeweiss, Sengwee Toh
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting. Pharmacoepidemiology and drug safety (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Christina Mortensen, Karina Dahl Steffensen, Emma Simonsen, Kamille Herskind, Jonna Skov Madsen, Dorte Aalund Olsen, Ditte Bork Iversen, Troels Korshøj Bergmann, Jesper Hallas, Tore Bjerregaard Stage
Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer. Pain (2022)
Signe Benzon Larsen, Christian Dehlendorff, Charlotte Skriver, Jesper Hallas, Søren Friis, Martin Andreas Røder, Martin Andreas Røder, Anne Katrine Duun-Henriksen
Prescription rates for commonly used drugs before and after a prostate cancer diagnosis. Cancer causes & control : CCC 33 (3) (2022)
Manon Cairat, Jesper Hallas, Morten Olesen, Laure Dossus, Agnès Fournier, Blánaid M Hicks
Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study. International journal of cancer (2022)
Kasper Bruun Kristensen, Lars Christian Lund, Peter Bjødstrup Jensen, Anne Broe, Emelie Curovic Rotbain, Per Damkier, Jesper Hallas, Jacob Harbo Andersen, Mikkel Højlund, Morten Olesen, Lotte Rasmussen, Morten Rix Hansen, Martin Thomsen Ernst, Rikke Wesselhoeft, Daniel Pilsgaard Henriksen, Mette Reilev, Mette Bliddal, Nina Sahlertz Kristiansen
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions. Clinical epidemiology 14 (2022)
Helene K Jensen, Lotte Rasmussen, Kari Furu, Øystein Karlstad, Marie Linder, Carolyn E Cesta, Jesper Hallas
Use of non-insulin antidiabetic drugs in children and young adults - A Scandinavian drug utilization study from 2010-2019. British journal of clinical pharmacology 87 (11) (2021)
Jesper Hallas, Carina Lundby, Dorte Ejg Jarbøl, Søren Post Larsen, Bettina Clauber Hoppe, Helene Hoffmann, Wade Thompson
Use of sedating medications around nursing home admission in Denmark. Pharmacoepidemiology and drug safety 30 (11) (2021)
Simone Bastrup Israelsen, Jesper Hallas, Håkon Sandholdt, Sten Madsbad, Reimar Wernich Thomsen, Thomas Benfield
Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2. Diabetes, obesity & metabolism 23 (6) (2021)
Jesper Hallas, Lucas Morin, Nina Sahlertz Kristiansen, Tobias Gerhard, Almut G Winterstein, Susanna Perez-Gutthann, Mina Tadrous
Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology. Pharmacoepidemiology and drug safety (2021)
Alejandro Arana, Jesper Hallas, Josephina G Kuiper, Helen Booth, Johan Reutfors, Brian Calingaert, Lars Christian Lund, Elizabeth Crellin, Marcus Schmitt-Egenolf, James A Kaye, Karin Gembert, Kenneth J Rothman, Helle Kieler, Daniel Dedman, Eline Houben, Lia Gutiérrez, Nina Sahlertz Kristiansen, Susanna Perez-Gutthann
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clinical epidemiology 13 (2021)
Rikke Wesselhoeft, Lotte Rasmussen, Peter Bjødstrup Jensen, Poul Jørgen Jennum, Svetlana Skurtveit, Ingeborg Hartz, Johan Reutfors, Per Damkier, Mette Bliddal, Jesper Hallas
Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia. Acta psychiatrica Scandinavica 144 (2) (2021)
Inge Raadal Skov, Daniel Pilsgaard Henriksen, Hanne Madsen, Jesper Hallas, Jesper Rømhild Davidsen
Changes in oral corticosteroid use in asthma treatment-A 20-year Danish nationwide drug utilisation study. Basic & clinical pharmacology & toxicology (2021)
Laurel A Habel, Ninah Achacoso, Bruce Fireman, Sidsel Arnspang Pedersen, Jesper Hallas
Hydrochlorothiazide and risk of melanoma subtypes. Pharmacoepidemiology and drug safety 30 (10) (2021)
Nina Sahlertz Kristiansen, Morten Rix Hansen, Jesper Hallas, Eeva-Liisa Røssell Johansen
Bottleneck analysis: Simple prediction of the precision of a planned case-control or cohort study based on healthcare registers. Pharmacoepidemiology and drug safety 30 (5) (2021)
Natascha Gaster, Nina Sahlertz Kristiansen, Jesper Hallas, Søren Friis, Morten Schmidt
The Validity of Danish Prescription Data to Measure Use of Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs and Quantification of Bias Due to Non-Prescription Drug Use. Clinical epidemiology 13 (2021)
Jesper Hallas, Tore Bjerregaard Stage
Translational pharmacology: Closing the mechanistic gap. Basic & clinical pharmacology & toxicology (2021)
Carina Lundby, Jesper Hallas
Considerations regarding choice of primary outcome in clinical trials in deprescribing. British journal of clinical pharmacology (2021)
Jesper Hallas, Lars Christian Lund, Øystein Karlstad, Jesper Dahl, Morten Andersen, Jesper Hallas, Øjvind Lidegaard, German Tapia, Hanne Løvdal Gulseth, Paz Lopez-Doriga Ruiz, Sara Viksmoen Watle, Anders Pretzmann Mikkelsen, Lars Pedersen, Henrik Toft Sørensen, Reimar Wernich Thomsen, Anders Hviid
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ (Clinical research ed.) 373 (2021)
Anna Elise Engell, Andreas Ludvig Ohm Svendsen, Bent Struer Lind, Tore Bjerregaard Stage, Maja Hellfritzsch, Jesper Hallas
Drug-drug interactions between vitamin K antagonists and statins: a systematic review. European journal of clinical pharmacology 77 (10) (2021)
Kasper Bruun Kristensen, Daniel Pilsgaard Henriksen, Nina Sahlertz Kristiansen, Jesper Hallas, Lars Christian Lund
Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis. Diabetologia 64 (7) (2021)
Jesper Hallas, Bodil Hammer Bech, Sidsel Arnspang Pedersen, Bo Christensen
Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings. Pharmacoepidemiology and drug safety 30 (11) (2021)
Macarius M Donneyong, Teng-Jen Chang, Jesper Hallas, Daniel N A Ankrah, Francis Asenso-Boadi, Vivian Addo-Cobbiah, Lydia Dsane-Selby, Nina Sahlertz Kristiansen
Prevalence and quality of antihypertensive therapy among hypertension patients enrolled in the Ghana National Health Insurance Scheme. Pharmacoepidemiology and drug safety 30 (11) (2021)
Charles Vestereghem, Rasmus Froberg Brøndum, Ursula G Falkmer, Jesper Hallas, Laurids Østergaard Poulsen, Martin Bøgsted
High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019. Clinical epidemiology 13 (2021)
Jesper Hallas, Morten Olesen, Bo Christensen, Morten Bondo Christensen, Jesper Hallas, Lotte Rasmussen
Who prescribes drugs to patients: A Danish register-based study. British journal of clinical pharmacology 87 (7) (2021)
Daniel J Ward, Sanne Gørtz, Martin Thomsen Ernst, Nynne Nyboe Andersen, Susanne K Kjaer, Nina Sahlertz Kristiansen, Steffen Christensen, Christian Fynbo Christiansen, Simone Bastrup Israelsen, Thomas Lars Benfield, Jesper Hallas, Tine Jess
The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection. The European respiratory journal (2021)
Anders Husby, Jesper Hallas, Anders Hviid
Association between inhaled corticosteroid use and COVID-19 outcomes. Pharmacoepidemiology and drug safety 30 (11) (2021)
Carina Lundby, Peter Glans, Trine Simonsen, Jens Soendergaard, Jesper Ryg, Henrik Hein Lauridsen, Jesper Hallas
Attitudes towards deprescribing: The perspectives of geriatric patients and nursing home residents. Journal of the American Geriatrics Society 69 (6) (2021)
Luz M León-Muñoz, Talita Duarte Salles, Ana Llorente, Yesika Díaz, Diana Puente, Jesper Hallas, Dolores Montero-Corominas, Consuelo Huerta
Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain. Pharmacoepidemiology and drug safety 30 (9) (2021)
Jesper Hallas, Sidsel Arnspang Pedersen, Armand Cognetta, Kasper Bruun Kristensen
No association between hydrochlorothiazide use and uveal melanoma. European journal of clinical pharmacology 76 (9) (2020)
Daniel R Morales, Steve V Morant, Thomas M MacDonald, Isla S Mackenzie, Alexander S F Doney, Lyn Mitchell, Marion Bennie, Chris Robertson, Nina Sahlertz Kristiansen, Jesper Hallas, Martin Thomsen Ernst, Li Wei, Lizzie Nicholson, Carole Morris, Ron M C Herings, Jetty A Overbeek, Elisabeth Smits, Robert W V Flynn
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands. Pharmacoepidemiology and drug safety 29 (3) (2020)
Anna Elise Engell, Andreas Ludvig Ohm Svendsen, Bent S Lind, Christen L Andersen, John S Andersen, Tora G Willadsen, Frederik Persson, Jesper Hallas
Drug-drug interaction between warfarin and statins: A Danish cohort study. British journal of clinical pharmacology 87 (2) (2020)
Katsiaryna Bykov, Shirley V Wang, Nina Sahlertz Kristiansen, Jesper Hallas, Malcolm Maclure, Joshua J Gagne
Bias in case-crossover studies of medications due to persistent use: A simulation study. Pharmacoepidemiology and drug safety 29 (9) (2020)
Alaa Burghle, Carina Lundby, Jesper Ryg, Jens Soendergaard, Jesper Hallas, Dorthe Susanne Nielsen, Trine Graabaek
Attitudes Towards Deprescribing Among Older Adults with Limited Life Expectancy and Their Relatives: A Systematic Review. Drugs & aging 37 (7) (2020)
Jesper Hallas, Lars Christian Lund, Daniel Pilsgaard Henriksen, Lars Folkestad, Maja Hellfritzsch, Jesper Hallas, Kasper Bruun Kristensen
Use of dipeptidyl peptidase-4 inhibitors and risk of splanchnic vein thrombosis: A Danish nationwide new-user active comparator cohort study. Diabetes, obesity & metabolism 23 (2) (2020)
Anne Broe, Per Damkier, Jesper Hallas, Nina Sahlertz Kristiansen, Mette Bliddal
Congenital Malformations in Denmark: Considerations for the Use of Danish Health Care Registries. Clinical epidemiology 12 (2020)
Lars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, Steffen Christensen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, Eeva-Liisa Røssell Johansen, Nanna Borup Johansen, Nikolai Constantin Brun, Nina Sahlertz Kristiansen, Jesper Hallas
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS medicine 17 (9) (2020)
Katrine Bødkergaard, Randi M Selmer, Nina Sahlertz Kristiansen, Lars J Kjerpeseth, Jesper Hallas, Eva Skovlund, Eeva-Liisa Røssell Johansen
Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling. Pharmacoepidemiology and drug safety 29 (9) (2020)
Jesper Hallas, Xavier Kurz, Nicholas Moore, Christian Fynbo Christiansen, Olaf Klungel
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. Pharmacoepidemiology and drug safety 29 (8) (2020)
Jesper Hallas, Kasper Bruun Kristensen, Mette Reilev, Lars Christian Lund, Martin Thomsen Ernst, Nina Sahlertz Kristiansen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, Henrik Toft Sorensen, Nanna Borup Johansen, Eeva-Liisa Røssell Johansen, Steffen Christensen, Marianne Kragh Thomsen, Anders Husby, Marianne Voldstedlund, Jesper Kjær, Nikolai C Brun
Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort. Clinical epidemiology 12 (2020)
Daniel R Morales, Steven V Morant, Thomas M MacDonald, Nina Sahlertz Kristiansen, Martin Thomsen Ernst, Jesper Hallas, Ron M C Herings, Elisabeth Smits, Jetty A Overbeek, Isla S Mackenzie, Alexander S F Doney, Lyn Mitchell, Marion Bennie, Chris Robertson, Li Wei, Lizzie Nicholson, Carole Morris, Robert W V Flynn
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis. British journal of clinical pharmacology 87 (3) (2020)

Jesper Hallas.css-eqlu8i{font-size:small;padding-left:4px;} (Anton Pottegard, Anton Pottegård, A Pottegård)

Publication Activity (10 Years)

Top Topics

Top Venues

Jesper Hallas (Anton Pottegard, Anton Pottegård, A Pottegård)